Nafeisa Dilixiati
Beijing, 100020, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Inhibition of macrophage migration inhibitory factor attenuates bleomycin-induced murine pulmonary fibrosis via the MAPK pathway.
Journal: Respiratory research
Published: December 14, 2025
Distinct comorbidity profiles and outcomes in asbestosis versus idiopathic pulmonary fibrosis: a 6-year prospective cohort study.
Journal: BMC pulmonary medicine
Published: September 10, 2025
Identification of Risk Factors for 30-Day and Frequent One-Year Readmissions in Chronic Obstructive Pulmonary Disease Patients Following Acute Exacerbation.
Journal: International journal of chronic obstructive pulmonary disease
Published: June 23, 2025
Nerandomilast, a PDE4B inhibitor, alleviates silica-induced lung inflammation and fibrosis by inhibition of NLRP3 inflammasome and TGF-β/Smad signalling.
Journal: British journal of pharmacology
Published: May 27, 2025
SPP1+ macrophages contribute to silica-induced pulmonary inflammation and fibrosis via the ERK/JNK signaling pathway.
Journal: American journal of respiratory cell and molecular biology
Published: March 29, 2025
The Value of FeNO and Peripheral Blood Eosinophils in Assessing Airway Eosinophilic Inflammation in Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
Journal: Cytopathology : official journal of the British Society for Clinical Cytology
Published: December 17, 2024
Nomograms for Predicting High Hospitalization Costs and Prolonged Stay among Hospitalized Patients with pAECOPD.
Journal: Canadian respiratory journal
Published: March 30, 2024
Inflammation mediates the association between furan exposure and the prevalence and mortality of chronic obstructive pulmonary disease: National Health and Nutrition Examination Survey 2013-2018.
Journal: BMC public health
Published: January 16, 2024
Showing 1-9 of 9
Last Updated: 09/26/2026